MNKD

#2576
Mannkind Corporation
2.7400 USD
+3.79%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
2.7400
2.7400
Range Annuel
2.2300
6.5100
Changement quotidien
+3.79%
Changement Mensuel
-1.08%
Evolution sur 6 mois
-48.30%
Changement Annuel
-48.30%
Clôture Précédente
2.6400
Open
2.7400
Bid
Ask
Low
2.7400
High
2.7400
Volume
81
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 844.1952 M
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
283.5
Price to sales ratio
5.25

MannKind Corporation

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

Nouvelles